G-FACTOR
G-Factor is a reaction environment whose goal is to support researchers with entrepreneurial vocation and new entrepreneurs in the Life Sciences field to become companies able to successfully establish themselves on the market, creating replicable and scalable models.
We support the new companies with capital, network, training and all the resources at our disposal in order to enable the startups to move from the prototype phase to the fundraising phase, developing the ability to attract capital, link them to product development milestones and finally reach the market.
CALL LIFE SCIENCE
G-FORCE
An innovative acceleration program tailored for Life Science entrepreneurs. The program aims to accelerate talents with a high technical-scientific profile and the growth of entrepreneurial teams with particular attention to the dimension of doing business.
G-Force has a total duration of 9 months and provides intensive daily training and mentoring activities for the first 3 months of acceleration and bi-weekly mentoring for the following 6 months. The 2020 acceleration program, due to the Covid-19 emergency, will take place remotely in the form of webinars, round tables, mentoring and personalized coaching for each entrepreneurial project covering all aspects of business creation and development in Life Sciences. In the second part of the program, networking events are planned to allow the meeting and the creation of connections between young startups and potential industrial partners and investors. Physical presence in Opificio Golinelli's places will start as soon as social distance rules will allow that
WELCOME KIT
- Access to a network of highly qualified mentors and partners
- Access to a network of investors
- Legal and patent support
- Regulatory advice
- Media Coverage & Communications
- Accomodation for residential phase (when covid-19 emergency will be end)
Network
We collaborate with dozens of entrepreneurs, teachers and managers with different specializations and professional backgrounds to cover all the needs of accelerated startups: from product development to business storytelling, from IP to negotiation, from hard skills to soft skills.
Diego Ardigo
R&D Rare Diseases Unit Head
Chiesi Group
Bernardo Balboni
Contamination Lab Chief
Unimore
MICHELE BARLETTA
Sales & Marketing Lead
Sanofi Genzyme
SARA BATTISTONI
HR Consultant
Stars & Cow
Francesco Bonvicini
Corporate HR Director
Alfasigma
Simone Borsci
Assistant Prof HF & Cognitive Ergonomics
Twente University
Luca Canepa
Executive Management and Board Roles, Advisory, Mentor
LVC Management Service and Consulting
Andrea Cavalli
Coordinatore Dottorato in Data science and computation
Università di Bologna
Filippo Cipriani
Head of Open Innovation Projects
Sanofi Genzyme
Aldo Cocchiglia
Consulting High-Tech in Health-Care
AC Consulting
Valeria Croce
European Patent Attorney
Jacobacci & Partners
Edoardo David
Investment Analyst
Mamacrowd
VALENTINA DE MATTEO
Innovation & Change Management Senior Consultant
Bip - Business Integration Partners
Enrico di Oto
CEO
OaCP
Giulia Falcone
Strategic Development Director
Rafarm
SIMONE FERRIANI
Professor
University of Bologna
Giuliana Gavioli
Head of Regulatory Affairs
B. Braun Avitum Ag
Daniele Gazzola
President, CTO & Founder
CellDynamics
STEVE GEDEON
Entrepreneurship Professor & Angel Investor
Ryerson
LEONARDO GIAGNONI
Investment Manager
IAG
Mavi Gianni
Attrice & Formatrice
Facilitatrice
ANTONELLA GRASSIGLI
Co-Founder & CEO | Angel Investor
Doorway Srl
Gabriele Grecchi
CEO
Silk Biomaterials
Bill Morrow
Founder
Angels Den
PASQUALE PIERIMARCHI
Chief Scientific Manager
Istituto di Farmacologia Traslazionale, CNR
LUCA ROSSETTINI
CEO & Founder
D-Orbit
Gianluca Sferrazza
Assegnista di Ricerca
CNR
LUCA SPACCAPELO
Head of Opportunity Evaluation Group
Chiesi Group
Carlo Tassi
CEO, Angel Investor
B-Engine
Giovanni Trombetti
Commercialista
Studio Trombetti
Henry Xu
Senior Fellow
The Wharton School
Diego Ardigo
R&D Rare Diseases Unit Head
Chiesi Group
Bernardo Balboni
Contamination Lab Chief
Unimore
MICHELE BARLETTA
Sales & Marketing Lead
Sanofi Genzyme
SARA BATTISTONI
HR Consultant
Stars & Cow
Francesco Bonvicini
Corporate HR Director
Alfasigma
Simone Borsci
Assistant Prof HF & Cognitive Ergonomics
Twente University
Luca Canepa
Executive Management and Board Roles, Advisory, Mentor
LVC Management Service and Consulting
Andrea Cavalli
Coordinatore Dottorato in Data science and computation
Università di Bologna
Filippo Cipriani
Head of Open Innovation Projects
Sanofi Genzyme
Aldo Cocchiglia
Consulting High-Tech in Health-Care
AC Consulting
Valeria Croce
European Patent Attorney
Jacobacci & Partners
Edoardo David
Investment Analyst
Mamacrowd
VALENTINA DE MATTEO
Innovation & Change Management Senior Consultant
Bip - Business Integration Partners
Enrico di Oto
CEO
OaCP
Giulia Falcone
Strategic Development Director
Rafarm
SIMONE FERRIANI
Professor
University of Bologna
Giuliana Gavioli
Head of Regulatory Affairs
B. Braun Avitum Ag
Daniele Gazzola
President, CTO & Founder
CellDynamics
STEVE GEDEON
Entrepreneurship Professor & Angel Investor
Ryerson
LEONARDO GIAGNONI
Investment Manager
IAG
Mavi Gianni
Attrice & Formatrice
Facilitatrice
ANTONELLA GRASSIGLI
Co-Founder & CEO | Angel Investor
Doorway Srl
Gabriele Grecchi
CEO
Silk Biomaterials
Bill Morrow
Founder
Angels Den
PASQUALE PIERIMARCHI
Chief Scientific Manager
Istituto di Farmacologia Traslazionale, CNR
LUCA ROSSETTINI
CEO & Founder
D-Orbit
Gianluca Sferrazza
Assegnista di Ricerca
CNR
LUCA SPACCAPELO
Head of Opportunity Evaluation Group
Chiesi Group
Carlo Tassi
CEO, Angel Investor
B-Engine
Giovanni Trombetti
Commercialista
Studio Trombetti
Henry Xu
Senior Fellow
The Wharton School
Our industrial partners are important international players in the world of life sciences operating in different business areas: from pharmaceutical to medical devices, from biotech to data science. Together with our industrial partners we help startups to create sustainable and scalable businesses.
Portfolio
124 applications have been received for the first call of G-Factor, Life Sciences Innovation : 30 of these have reached the final stage and 10 have been selected to participate in the acceleration process which has end in December 2019 with the awaited Investor Day. Each Startup has received an investment of €100,000 €
medtechBCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.
medtechAdam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled
bioengineeringComplexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.
medtechDiamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.
bioengineeringeVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.
medtechGenoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.
medtechHoley has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.
medtechMgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.
medtechP4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.
medtechRELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.
137 applications have been received for the second call of G-Factor, Life Sciences Innovation 2020: 24 of these have reached the final stage and 5 have been selected to participate in the acceleration process which will end in December 2020 with the awaited Investor Day. Each Startup will receive an investment of €125,000 of which € 90,000 of liquidity and € 35,000 in kinds.
nutraceuticaThanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.
pharmaMicro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.
medtechRECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.
medtechAn innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.
medtechInnovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.
medtechBCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.
medtechAdam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled
bioengineeringComplexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.
medtechDiamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.
bioengineeringeVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.
medtechGenoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.
medtechHoley has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.
medtechMgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.
medtechP4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.
medtechRELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.
nutraceuticaThanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.
pharmaMicro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.
medtechRECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.
medtechAn innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.
medtechInnovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.
Team
Ing. Antonio Danieli
Director General and Board Member
@ Fondazione Golinelli
CEO @ G-Factor Incubator-Accelerator
Dott.ssa Cristiana Vignoli
Director @ G-Factor Incubator-Accelerator
c.vignoli@fondazionegolinelli.it
